Amine goldmine: BASF commits to new plant citing growing demand
The amines market will grow 5% over the next decade according to BASF, which cited rising drugmaker demand as a key driver for its investment in a new German plant.
Archives for April 15, 2014
Private equity investments scare pharma clients, says CRO
Pharmaceutical clients view contract research organisations (CROs) with private equity investments as unstable and more focused on financial growth than their operations, according to Italian CRO Cromsource.
CROs moving away from strategic partnerships? Survey investigates
As larger partnerships between CROs and sponsors come to maturity, a new survey found that “a much greater proportion of CRO revenue growth” will come from small and medium-sized pharma and biotech sponsor deals.
Discovery of tampered vials leads to Roche cancer drug recall
Roche has recalled nine batches of breast cancer drug Herceptin after tampered vials were discovered in the UK, Finland and Germany.
Catalent to provide cell lines for at least three Hisun biosimilars in China
Catalent will provide Hisun Pharmaceuticals with cell lines to help it develop infliximab, adalimumab and alemtuzumab biosimilars for the Chinese market.
Thermo Fisher: new pumps compatible with all bioprocessing techs
Thermo Fisher has launched a pump technology designed for applications across the bioprocessing production line and usable with "all" bioprocessing tech.